Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › HEYL as a therapeutic target and a diagnostic marker for neoplasia and uses therefor

HEYL as a therapeutic target and a diagnostic marker for neoplasia and uses therefor

US Patent 9540694 · Granted Jan 10, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Quantitative multiplex methylation specific PCR method-CMethDNA, reagents, and i2025
Quantitative multiplex methylation specific PCR method—cMethDNA, reagents, and i2019
Genome-wide methylation analysis and use to identify genes specific to breast ca2019
Quantitative multiplex methylation-specific PCR2016
Compositions and methods for treatment of tamoxifen resistant breast cancer2015
Quantitative multiplex methylation-specific PCR2014
Breast endothelial cell expression patterns2013
Claudins as markers for early detection, diagnosis, prognosis and as targets of 2012
Quantitative multiplex methylation-specific PCR2011
Aberrantly methylated genes as markers of breast malignancy2010
Prophylactic and therapeutic treatment of the ductal epithelium of a mammary gla2007
Prophylactic and therapeutic treatment of the ductal epithelium of a mammary gla2005